参考文献/References:
[1] Gehl J. Electroporation:theory and methods,perspectives for drug delivery,gene therapy and research[J]. Acta Physiol Scand,2003,177(4):437-447.
[2] Brock RM,Beitel-White N,Davalos RV,et al. Starting a fire without flame:the induction of cell death and inflammation in electroporation-based tumor ablation strategies[J]. Front Oncol,2020,10:1235.
[3] Liu ZG,Chen XH,Yu ZJ,et al. Recent progress in pulsed electric field ablation for liver cancer[J]. World J Gastroenterol ,2020,26(24):3421-3431.
[4] Nesin V,Bowman AM,Xiao S,et al. Cell permeabilization and inhibition of voltage-gated Ca(2+) and Na(+) channel currents by nanosecond pulsed electric field[J]. Bioelectromagnetics ,2012,33(5):394-404.
[5] Ben-David E,Ahmed M,Faroja M,et al. Irreversible electroporation:treatment effect is susceptible to local environment and tissue properties[J]. Radiology,2013,269(3):738-747.
[6] Lavee J,Onik G,Mikus P,et al. A novel nonthermal energy source for surgical epicardial atrial ablation:irreversible electroporation[J]. Heart Surg Forum,2007,10(2):E162-167.
[7] Yao C,Dong S,Zhao Y,et al. Bipolar microsecond pulses and insulated needle electrodes for reducing muscle contractions during irreversible electroporation [J]. IEEE Trans Biomed Eng,2017,64(12):2924-2937.
[8] Stewart MT,Haines DE,Verma A,et al. Intracardiac pulsed field ablation:proof of feasibility in a chronic porcine model[J]. Heart Rhythm ,2019,16(5):754-764.
[9] Leshem E,Zilberman I,Tschabrunn CM,et al. High-power and short-duration ablation for pulmonary vein isolation:biophysical?characterization[J]. JACC Clin Electrophysiol,2018,4(4):467-479.
[10] Reddy VY,Koruth J,Jais P,et al. Ablation of atrial fibrillation with pulsed?electric fields:an ultra-rapid,tissue-selective modality for cardiac ablation[J]. JACC Clin Electrophysiol ,2018,4(8):987-995.
[11] Livia C,Sugrue A,Witt T,et al. Elimination of purkinje fibers by electroporation reduces ventricular fibrillation vulnerability[J]. J Am Heart Assoc,2018,7(15):e009070.
[12] Madhavan M,Venkatachalam KL,Swale MJ,et al. Novel percutaneous epicardial autonomic modulation in the canine for atrial fibrillation:results of an efficacy and safety study[J]. Pacing Clin Electrophysiol,2016,39(5):407-417.
[13] Sugrue A,Vaidya VR,Livia C,et al. Feasibility of selective cardiac ventricular electroporation[J]. PLoS One,2020,15(2):e0229214.
[14] Ha?ssaguerre M,Ja?s P,Shah DC,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J]. N Engl J Med,1998,339(10):659-666.
[15] van Driel VJ,Neven KG,van Wessel H,et al. Pulmonary vein stenosis after catheter ablation:electroporation versus radiofrequency[J]. Circ Arrhythm Electrophysiol,2014,7(4):734-738.
[16] Witt CM,Sugrue A,Padmanabhan D,et al. Intrapulmonary vein ablation without stenosis:a novel balloon-based direct current electroporation approach[J]. J Am Heart Assoc,2018,7(14):e009575.
[17] Howard B,Haines DE,Verma A,et al. Reduction in pulmonary vein stenosis and collateral damage with pulsed field ablation compared with radiofrequency ablation in a canine model[J]. Circ Arrhythm Electrophysiol ,2020,13(9):e008337.
[18] Kuroki K,Whang W,Eggert C,et al. Ostial dimensional changes after pulmonary vein isolation:pulsed field ablation vs radiofrequency ablation[J]. Heart Rhythm,2020,17(9): 1528-1535.
[19] Loh P,van Es R,Groen MHA,et al. Pulmonary vein isolation with single pulse irreversible electroporation:a first in human study in 10 patients with atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2020,13(10):e008192.
[20] Bradley CJ,Haines DE. Pulsed field ablation for pulmonary vein isolation in the treatment of atrial fibrillation[J]. J Cardiovasc Electrophysiol,2020,31(8):2136-2147.
[21] Koruth JS,Kuroki K,Kawamura I,et al. Pulsed field ablation versus radiofrequency ablation:esophageal injury in a novel porcine model[J]. Circ Arrhythm Electrophysiol,2020,13(3):e008303.
[22] Hong J,Stewart MT,Cheek DS,et al. Cardiac ablation via electroporation [J]. Annu Int Conf IEEE Eng Med Biol Soc,2009,2009:3381-3384.
[23] Neven K,van Es R,van Driel V,et al. Acute and long-term effects of full-power electroporation ablation directly on the porcine esophagu s[J]. Circ Arrhythm Electrophysiol ,2017,10(5):e004672.
[24] Maor E,Ivorra A,Leor J,et al. The effect of irreversible electroporation on blood vessels [J]. Technol Cancer Res Treat ,2007,6(4):307-312.
[25] Pothineni NV,Kancharla K,Katoor AJ,et al. Coronary artery injury related to catheter ablation of cardiac arrhythmias:a systematic review[J]. J Cardiovasc Electrophysiol ,2019,30(1):92-101.
[26] van Driel VJ,Neven K,van Wessel H,et al. Low vulnerability of the right phrenic nerve to electroporation ablation [J]. Heart Rhythm ,2015,12(8):1838-1844.
[27] Caluori G,Odehnalova E,Jadczyk T,et al. AC pulsed field ablation is feasible and safe in atrial and ventricular settings:a proof-of-concept chronic animal study[J]. Front Bioeng Biotechnol ,2020,8:552357.
[28] Yavin H,Shapira-Daniels A,Barkagan M,et al. Pulsed field ablation using a lattice electrode for focal energy delivery:biophysical characterization, lesion durability,and safety evaluation[J]. Circ Arrhythm Electrophysiol,2020,13(6):e008580.
[29] Reddy VY,Neuzil P,Koruth JS,et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation[J]. J Am Coll Cardiol,2019,74(3):315-326.
[30] Reddy VY,Anter E,Rackauskas G,et al. Lattice-tip focal ablation catheter that toggles between radiofrequency and pulsed field energy to treat atrial fibrillation:a first-in-human trial[J]. Circ Arrhythm Electrophysiol ,2020,13(6):e008718.
[31] Padmanabhan D,Naksuk N,Killu AK,et al. Electroporation of epicardial autonomic ganglia:safety and efficacy in medium-term canine models[J]. J Cardiovasc Electrophysiol ,2019,30(4):607-615.
[32] Koruth JS,Kuroki K,Iwasawa J,et al. Endocardial ventricular pulsed field ablation:a proof-of-concept preclinical evaluation[J]. Europace,2020,22(3):434-439.
[33] Haines DE,Stewart MT,Dahlberg S,et al. Microembolism and catheter ablation I:a comparison of irrigated radiofrequency and multielectrode-phased radiofrequency catheter ablation of pulmonary vein ostia[J]. Circ Arrhythm Electrophysiol ,2013,6(1):16-22.
[34] Wojtaszczyk A,Caluori G,Pe?l M,et al. Irreversible electroporation ablation for atrial fibrillation [J]. J Cardiovasc Electrophysiol,2018,29(4):643-651.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(1):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(1):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(1):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(1):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]